Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease leading to kidney failure. To date, there is no cure for the disease although there is one approved disease-modifying therapy: tolvaptan. In this context, a common question that ADPKD patients ask in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Albert C M, Torra, Roser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155227/
https://www.ncbi.nlm.nih.gov/pubmed/35664267
http://dx.doi.org/10.1093/ckj/sfac103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9155227/
https://www.ncbi.nlm.nih.gov/pubmed/35664267
http://dx.doi.org/10.1093/ckj/sfac103

Ejemplares similares